13D Filing: Aisling Capital III LP and Agile Therapeutics Inc (AGRX)

Page 5 of 11

Page 5 of 11 – SEC Filing

CUSIP No. 00847L100
SCHEDULE 13D
Page 5 of 11

1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Steven Elms
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3
SEC USE ONLY
4
SOURCE OF FUNDS
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
961
8
SHARED VOTING POWER
1,304,933
9
SOLE DISPOSITIVE POWER
961
10
SHARED DISPOSITIVE POWER
1,304,933
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,854,987
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.8% (See Item 5)
14
TYPE OF REPORTING PERSON
IN

Follow Agile Therapeutics Inc (NASDAQ:AGRX)

Page 5 of 11